Capital Asset Advisory Services’s Novartis NVS Stock Holding History

Capital Asset Advisory Services’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$265K	Sell	1,689 -8	-0.5%	-$1.2K	0.01%	301
2026 Q1	$256K	Sell	1,697 -358	-17%	-$54.9K	0.01%	257
2025 Q4	$292K	Buy	2,055 +85	+4%	+$11.1K	0.01%	237
2025 Q3	$253K	Sell	1,970 -222	-10%	-$27.1K	0.01%	250
2025 Q2	$270K	Sell	2,192 -292	-12%	-$32.9K	0.01%	233
2025 Q1	$275K	Buy	+2,484	New	+$264K	0.01%	234
2021 Q1	–	Sell	-1,088	Closed	-$103K	–	1224
2020 Q4	$103K	Buy	+1,088	New	+$95.1K	0.02%	455

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital Asset Advisory Services's NVS Position: Q2 2026 in Review

Capital Asset Advisory Services reduced its Novartis (NVS) stake by 0.47% in Q2 2026, selling an estimated $1.2K and leaving 1,689 shares worth $265K. The position accounts for 0.01% of the portfolio, ranked #301.

Capital Asset Advisory Services first reported a position in NVS in Q4 2020 and has held it in 7 quarters since. The position peaked at $292K in Q4 2025. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Capital Asset Advisory Services held 1,689 shares of Novartis worth $265K as of Q2 2026.
Capital Asset Advisory Services sold 8 Novartis shares in Q2 2026, an estimated $1.2K.
Novartis made up 0.01% of Capital Asset Advisory Services's portfolio in Q2 2026, its #301 holding.
Capital Asset Advisory Services first reported a position in Novartis in Q4 2020 and has held it in 7 quarters since.
Capital Asset Advisory Services's Novartis position peaked at $292K in Q4 2025.
1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Capital Asset Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.